TTP399: A Potential First-in-Class Adjunct Therapy in Type 1 Diabetes
Nearly 80 percent of people with type 1 diabetes (T1D) fail to meet HbA1c goals defined by the American Diabetes…
Saving Vision, Changing Lives
Several decades ago, type 1 diabetes (T1D) patients brought their seeing-eye dogs into the offices where Jennifer Sun, M.D., MPH.,…
A Scientist Sees Kidney Disease Through New Eyes
Monika Niewczas is keenly focused on kidneys. Specifically, making sure that they don’t stop working when someone develops type 1…
What is Autoimmune Disease?
It’s Autoimmune Disease Awareness Month, but what are autoimmune diseases? Good question. They occur when a person’s immune system mistakenly…
Collaboration and a Connection to T1D Researchers: Breakthrough T1D-nPOD Annual Meeting
I’ve just gotten back from the 12th Network for Pancreatic Organ Donors with Diabetes (nPOD) Annual Meeting, which was held…
New Breakthrough T1D-Funded Study finds Lifetime T1D Management Costs a Collective $813 Billion
Cost for each diagnosed American is nearly $500,000.
ATTD Conference Brings Together Top Minds in Diabetes Research
Each year diabetes researchers from all over the world gather for the annual meeting of the Advanced Technologies & Treatments…
Breakthrough T1D Mission Summit Salutes Type 1 Diabetes Research
Ellen Leake, Chair of the International Board of Directors
Breakthrough T1D Awards World-Renowned T1D Researchers
Breakthrough T1D is honored to recognize five leading international researchers whose work has and is transforming type 1 diabetes (T1D)…
Study: Disease-Modifying Therapies Needed to Offset Costs of Type 1 Diabetes
A new study commissioned by the Breakthrough T1D T1D Fund spotlights the high economic burden of type 1 diabetes (T1D)…
